П. И. Феоктистов

ORCID: 0000-0001-6024-5817
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Venous Thromboembolism Diagnosis and Management
  • Cardiac tumors and thrombi
  • Helminth infection and control
  • Vascular anomalies and interventions
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Blood transfusion and management
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Plant Diversity and Evolution
  • Multiple and Secondary Primary Cancers
  • Sarcoma Diagnosis and Treatment
  • Renal and Vascular Pathologies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Animal Nutrition and Physiology
  • Central Venous Catheters and Hemodialysis
  • Plant and animal studies
  • Plant and Fungal Species Descriptions
  • Spine and Intervertebral Disc Pathology
  • Erythropoietin and Anemia Treatment
  • Veterinary Practice and Education Studies
  • Anesthesia and Pain Management
  • Erythrocyte Function and Pathophysiology
  • Medical Imaging and Pathology Studies
  • Plant Virus Research Studies
  • Spinal Hematomas and Complications

Ministry of Health
2022-2023

Ministry of Health of the Russian Federation
2021

Russian Cancer Research Center NN Blokhin
2016

Objective: to assess the results of nephrectomy, thrombectomy in RCC patients with level III–IV tumor venous thrombosis and without cardiopulmonary bypass. Materials methods. Medical data 167 consecutive underwent nephrectomy N.N. Blokhin Russian Cancer Research Center between 1998 2012 were collected. Right side was 122 (73.1 %), left – 42 (25.1 bilateral 3 (1.8 %) cases. The extent thrombus defined as intrahepatic 82 (49.1 supradiaphragmatic 85 (50.9 (intrapericardial 44 (26.3 intraatrial...

10.17650/1726-9776-2016-12-4-21-34 article EN Cancer Urology 2016-01-01

Objective. To evaluate short-term and long-term results of nephrectomy, thrombectomy, circular inferior vena cava (IVC) resection in patients with renal cell carcinoma (RCC) advanced IVC tumor invasion. Materials methods . Medical data 49 RCC level II–IV venous thrombus wall invasion were analyzed. All the underwent (radical – 35 (71.0 %), cytoreductive, M+ cases 14 (28.6 %)). Circular infrarenal segment was performed 25 (51.0 %) patients; infrarenal, perirenal retrohepatic segments a...

10.17650/1726-9776-2017-13-1-27-36 article EN Cancer Urology 2017-01-01

Objective: to develop an effective and safe surgical technique for the treatment of patients with renal cell carcinoma invasive tumor venous thrombosis inferior vena cava (IVC). Materials methods. The study included 75 underwent at N.N. Blokhin Russian Cancer Research Center between 1995 2017. median age was 57 years (range: 32–72 years). All were diagnosed RCC levels II–IV; them, 55 (73.3 %) had complete IVC obstruction mature collaterals. Twenty- seven (26.0 regional, 37 (49.3 – distant...

10.17650/1726-9776-2018-14-2-15-25 article EN Cancer Urology 2018-07-07

Objective: to identify the predictors of perioperative complications and deaths in surgically treated patients with kidney cancer complicated by venous tumor thrombosis. Subjects methods. The investigation included data on 463 venous patients, median age was 57 years. male / female ratio 2.5:1. Perirenal, subhepatic, retrohepatic, supradiaphragmatic thrombi were diagnosed in 161 (34.8 %), 135 (29.2 82 (17.7 85 (18.3 %) patients, respectively. Regional distant metastases occurred 90 (19.4...

10.17650/1726-9776-2014-10-3-31-39 article EN DOAJ (DOAJ: Directory of Open Access Journals) 2014-11-01

Background. The development of anesthesiology allows performing combined operations in patients with locally advanced malignant tumors. A logical companion aggressive cancer surgery is a massive blood loss, which can be so pronounced that it poses threat to the life patient.
 Objective. presented experience an example transformation nearly fatal situation into curable one and useful choosing active treatment strategy most desperate situations.
 Methods. This research includes 25...

10.17816/clinpract10342-48 article EN cc-by-nc-nd Journal of clinical practice 2019-11-06

Objective : to evaluate the outcomes of thrombectomy performed using different surgical techniques in renal cell carcinoma (RCC) patients with extensive tumor venous thrombosis. Materials and methods . This study included 345 RCC thrombosis who underwent treatment. The median age was 57 years (range: 16—79 years); male-to-female ratio 1:1.9. Two hundred sixty (75.4 %) had their thrombus originating from right vein, 85 (24.6 — left vein. In 169 (49.0 %), spread retrohepatic inferior vena cava...

10.17650/1726-9776-2021-17-1-19-30 article EN Cancer Urology 2021-05-06

Objective : to assess the early and late functional results of partial nephrectomy in patients with solitary functioning kidney tumors. Materials methods . Medical data 131 consecutive parenchymal tumor, who had undergone at N. Blokhin Russian Cancer Research Center, were analyzed. The median age was 57 (26–75) years. All diagnosed tumor (median RENAL score 7.0 ± 2.4 PADUA 9.0 2.2). baseline glomerular filtration rate (GFR) 74 (33–159) ml/min/1.73 m2 (30 (22.9 %) – stage III chronic disease...

10.17650/1726-9776-2017-13-3-46-53 article EN Cancer Urology 2017-01-01

Background. The only effective treatment for renal cell carcinoma with tumor inferior vena cava (IVC) thrombosis is surgery. Nephrectomy thrombectomy (NETE) usually associated clinically significant blood loss. role of blood-sparing methods using autoerythrocyte reinfusion device (ARD) or replacement loss donor erythrocytes (DE) on the outcomes NETE has not been well studied.
 Aim. To study rate hemostasis disorders intraoperative ARD use, as effect and DE transfusions specific (SS),...

10.26442/18151434.2023.1.202103 article EN Journal of Modern Oncology 2023-05-17

Background. An effective treatment for renal cell carcinoma complicated by tumor thrombus (TT) is nephrectomy with thrombectomy (NETE) from the inferior vena cava (IVC), which associated massive blood loss, high morbidity and mortality. The study aims to evaluate infusion-transfusion protocol (ITP) NETE IVC without extracorporeal circulation.
 Materials methods. observational single-center included 682 patients who were operated TT. Patients divided into 3 groups depending on level of...

10.26442/20751753.2022.6.201705 article EN cc-by Consilium Medicum 2022-08-15

Введение. Расширенные комбинированные вмешательства являются основным методом лечения пациентов с местнораспространенными солидными злокачественными опухолями. Основным следствием масштабной онкохирургии является риск развития острой массивной кровопотери (ОМОК). Цель исследования: оценка переносимости ОМОК у онкологических больных. Материалы и методы. В одноцентровое ретроспективное исследование января 1999 г. по декабрь 2018 были включены 4236 больных, оперированных в радикальном объёме...

10.25555/thr.2021.4.0995 article RU Тромбоз гемостаз и реология 2021-11-30
Coming Soon ...